ALFA Finder
The call ran from 12:31 PM to 1:25 PM IST (55 min).
Key takeaways
Q2 revenue ₹732 Cr, +16% YoY; H1 ₹1,410 Cr, +15%. EBITDA margin 19.7% despite ~₹6 Cr wage-revision hit. Trade-margin cap guided at mid-to-high single-digit annualised impact, with few specifics.
| Revenue growth | Q2 +16% YoY; ex-North Bangalore +14%; volume and ARPP driven. |
|---|---|
| Margins | EBITDA margin 19.7% vs 19.2%; wage revision cost ~₹6 Cr. |
| Demand visibility | Healthy patient demand; cancer incidence and screening cited as tailwinds. |
| Management confidence | Confident; trade-margin impact acknowledged but largely deflected to levers. |
Growth
Q2 revenue +16% (ex-North Bangalore +14%), volume +9%, ARPP +7%; EBITDA +17%, margin 19.7% (vs 19.2%).
Outlook
Guidance: mid-teens revenue, high-teens EBITDA growth through FY29; tax 35-40% near term.
Risks
Trade-margin cap (from November) hits mid-to-high single-digit annualised EBITDA; H1 OCF/EBITDA only ~54%.
Last quarter's promises, checked
Delivered
- Mid-teens rev growth → Q2 +16%, H1 +15% (= BEAT)
- ₹170 Cr debt repayment → ₹170 Cr repaid (= BEAT)
- EBITDA growth > revenue → Q2 EBITDA +17% vs rev +16% (= BEAT)
Partly delivered
- 21-22% EBITDA margin in 2 yrs → Q2 19.7% (Q1 adj 19.4%) (= PARTIAL)
- NB losses to peak in Q1 then fall → no Q2 NB loss disclosed (= PARTIAL)
- ESOP charge to be reported in Q2 → not in current data (= PARTIAL)
Summary by ALFA Finder, written with AI assistance from our own recording of the call, published . Open it on ALFA Filings ›
The results behind this call
Healthcare Global Enterprises Q2 FY27 Results: Net Profit ₹9.2 Cr, Down 55.6% YoY
Healthcare Global Enterprises Ltd reported revenue from operations of ₹731.8 Cr (+13.1% YoY) and net profit of ₹9.2 Cr (-55.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹9.2 Cr · -55.6% YoY
What management said last time
Full summary →From the call summary published .
Outlook they gave
Commissioned 120+ bed North Bangalore hospital; added 121 operational beds across network this quarter.
Growth they described
Revenue hit INR 6,951 Mn with 11% volume growth. Adjusted EBITDA margins expanded 120bps to 19.4% due to higher non-institutional business.
Call details
| Company | Healthcare Global Enterprises Limited |
|---|---|
| NSE symbol | HCG |
| ISIN | INE075I01017 |
| Call | Q2 FY27 earnings call |
| Date | Friday, 6 November 2026 |
| Time | 12:30 PM IST |
| Length | 55 min |
| Audio | Our stream on YouTube ↗ |
Healthcare Global Enterprises Limited: key numbers
- Share price
- ₹600.25
- Market cap
- ₹8,962 Cr
- Revenue (annual)
- ₹2,545 Cr
- Net profit (annual)
- ₹13.76 Cr
- P/E (TTM)
- 793.1×Sector 53.9×
- Promoter holding
- 64.21%+0.00% QoQ
- FII holding
- 2.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Other calls on Fri, 6 Nov
Today's concalls →
